Cliff Asness’s ClearPoint Neuro CLPT Stock Holding History

Cliff Asness’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13,614	Closed	-$242K	–	2211
2021 Q3	$242K	Buy	+13,614	New	+$255K	﹤0.01%	2101

Other funds holding CLPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

GPC

Guardian Point Capital Charlottesville, Virginia $325M AUM 40.6% 1-Year Est. Return

Cliff Asness's CLPT Position: Q4 2021 in Review

Cliff Asness sold out of ClearPoint Neuro (CLPT) in Q4 2021, closing a stake of 13,614 shares — an estimated $242K sold.

Cliff Asness first reported a position in CLPT in Q3 2021 and held it in 1 quarter. The position peaked at $242K in Q3 2021. 67 funds tracked by Wall St. Rank hold CLPT as of Q4 2021.

Cliff Asness reported no remaining ClearPoint Neuro position as of Q4 2021 after selling out during the quarter.
Cliff Asness sold 13,614 ClearPoint Neuro shares in Q4 2021, an estimated $242K.
Cliff Asness first reported a position in ClearPoint Neuro in Q3 2021 and held it in 1 quarter.
Cliff Asness's ClearPoint Neuro position peaked at $242K in Q3 2021.
67 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2021.

Based on AQR Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.